Eli Lilly, the manufacturer of Zepbound, which is FDA-approved to help treat obesity and obesity with obstructive sleep apnea ...

Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug ...

ResMed has launched a rebrand to unify its portfolio and reflect its increasing direct-to-consumer engagement.

Zepbound is the name of the first drug approved by the FDA for obstructive sleep apnea. According to the Mayo Clinic, obstructive sleep apnea is a common sleep-related breathing disorder that ...

(Ivanhoe Newswire) --- Obstructive sleep apnea, or OSA, affects nearly a billion ... also known as Mounjaro or Zepbound. “It’s called GLP one receptor,” said Atul Malhotra, MD from the ...

Eligible patients diagnosed by a health-care provider with obesity alone or along with obstructive sleep apnea — Zepbound's newly approved use — can pay for those vials themselves on the site.

The Food and Drug Administration (FDA) approved Zepbound in December 2024 for treating obstructive sleep apnea (OSA). Medicare Part D may cover Zepbound, but only when a doctor prescribes it for OSA.

The makers of two popular weight-loss drugs—Wegovy and Zepbound—are cutting prices to make the medications more affordable for people without insurance. Novo Nordisk, the Danish company behind Wegovy, ...

Obstructive sleep apnea (OSA) is associated with an increased risk for Parkinson disease (PD), according to a study s ...

People with obstructive sleep apnea have an increased risk of Parkinson's disease, but if started early enough, continuous ...

The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity. "GMA" shares an exclusive look ...